Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
189.15B
Market cap189.15B
Price-Earnings ratio
10.61
Price-Earnings ratio10.61
Dividend yield
2.83%
Dividend yield2.83%
Average volume
8.89M
Average volume8.89M
High today
$43.14
High today$43.14
Low today
$42.41
Low today$42.41
Open price
$42.73
Open price$42.73
Volume
8.86M
Volume8.86M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

Simply Wall St 6h
Novo Nordisk Unveils Novo Rebrand And The Novo Way Reset

Novo Nordisk (NYSE:NVO) is rebranding globally to the shorter corporate name Novo as part of a broad identity shift. The group is rolling out a refreshed cultu...

Novo Nordisk Unveils Novo Rebrand And The Novo Way Reset
The Motley Fool 6h
Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything

Eli Lilly (LLY +0.11%) has been on a historic run over the past five years, outperforming similarly sized peers in the pharmaceutical industry and becoming the...

Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything
24/7 Wall St. 8h
Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption

Investing Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption A landmark trial just proved semaglutide can pull children as young as...

Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption

More NVO News

Nasdaq 11h
Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Key Points Novo Nordisk continues to dominate the global diabetes and obesity care markets with its portfolio of blockbuster GLP-1 therapies. Regeneron Pharma...

Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
TipRanks 12h
Novo Nordisk Stock Is Falling Despite Rebrand to ‘Novo’ — Here’s Why

Novo Nordisk shares (NVO) fell by 1% to around $43 per share early Tuesday. This came even after the popular obesity drugmaker rebranded simply to “Novo” on Mon...

TipRanks 14h
Novo Nordisk rebranding as ‘Novo,’ announces cultural reset

Novo Nordisk (NVO) is changing its day-to-day name to “Novo” and taking a new approach to company culture, the company said on Monday. The company set out on Mo...

TipRanks 14h
Ascendis Pharma downgraded to Outperform from Strong Buy at Raymond James

Raymond James downgraded Ascendis Pharma (ASND) to Outperform from Strong Buy with an unchanged price target of $287 after the company announced it will regain...

TipRanks 1d
Novo Nordisk Kept at Hold as Analyst Maintains $47 Price Target Amid Strategic Uncertainty

BMO Capital analyst Evan Seigerman maintained a Hold rating on Novo Nordisk yesterday and set a price target of $47.00. Evan Seigerman has given his Hold ratin...

MarketWatch 1d
Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars

Novo Nordisk, the Danish drug giant behind Ozempic, is streamlining its corporate culture and shortening its name as it tries to better compete in the market fo...

Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars
The Wall Street Journal 2d
Novo Nordisk to Rebrand as Novo

Novo will be used on a day-to-day basis, while Novo Nordisk A/S will remain it's legal global company name. Tom Little / Reuters Wegovy maker Novo Nordisk NOVO...

Novo Nordisk to Rebrand as Novo

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.